WS Data Solutions
Discounted Cash Flow Rating
Buy
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Strong Buy
Price to Earnings Rating
Strong Sell
Analyst Rating
Neutral
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Neutral
Wall Street Data Solutions Rating
Neutral
B
Amicus Therapeutics, Inc (FOLD)
Pharmaceutical Preparations
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
3675 MARKET STREET
PHILADELPHIA, PA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
05/31/2007
Market Cap
3,379,654,445
Shares Outstanding
293,250,000
Weighted SO
293,245,738
Total Employees
N/A
Upcoming Earnings
N/A
Beta
0.7110
Last Div
0.0000
Range
9.02-14.57
Chg
-0.0550
Avg Vol
2644166
Mkt Cap
3379654445
Exch
NASDAQ
Country
US
Phone
215 921 7600
DCF Diff
1.0766
DCF
11.7534
Div Yield
0.0000
P/S
7.4171
EV Multiple
-109.2287
P/FV
26.1200
Div Yield %
0.0000
P/E
-28.9578
PEG
-1.2967
Payout
0.0000
Current Ratio
2.7471
Quick Ratio
2.2633
Cash Ratio
1.2456
DSO
68.2282
DIO
564.1212
Op Cycle
632.3494
DPO
222.3811
CCC
409.9682
Gross Margin
0.8845
Op Margin
-0.0602
Pretax Margin
-0.2191
Net Margin
-0.2623
Eff Tax Rate
-0.2599
ROA
-0.1595
ROE
-0.8590
ROCE
-0.0472
NI/EBT
1.1973
EBT/EBIT
3.6406
EBIT/Rev
-0.0602
Debt Ratio
0.5298
D/E
2.9961
LT Debt/Cap
0.7459
Total Debt/Cap
0.7498
Int Coverage
116.6979
CF/Debt
-0.1055
Equity Multi
5.6555
Rec Turnover
5.3497
Pay Turnover
1.6413
Inv Turnover
0.6470
FA Turnover
8.4738
Asset Turnover
0.6080
OCF/Share
-0.1379
FCF/Share
-0.1583
Cash/Share
0.8561
OCF/Sales
-0.0919
FCF/OCF
1.1481
CF Coverage
-0.1055
ST Coverage
-5.1643
CapEx Coverage
-6.7515
Div&CapEx Cov
-6.7515
P/BV
26.1200
P/B
26.1200
P/S
7.4171
P/E
-28.9578
P/FCF
-70.2660
P/OCF
-82.6273
P/CF
-82.6273
PEG
-1.2967
P/S
7.4171
EV Multiple
-109.2287
P/FV
26.1200
DPS
0.0000